Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include: Ganglioneuroblastoma, Elevated urinary dopamine level, Ataxia, and Elevated urinary catecholamine level and 20 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 4 | Elevated urinary dopamine level, Elevated urinary catecholamine level, Elevated urinary homovanillic acid |
Biomarker and diagnostic research for neuroblastoma, susceptibility to, 1 has been reported in the published literature.
No clinical trials have been registered for neuroblastoma, susceptibility to, 1.
84 publications have been identified in PubMed for neuroblastoma, susceptibility to, 1. Kisho has analyzed 61 by research type. Research spans Epidemiology / Natural History (46%), Basic Science / Preclinical (31%), and Review / Meta-Analysis (13%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 28 | 46% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 3:02 PM UTC
Online Mendelian Inheritance in Man
Digestive system
3 |
Abdominal mass, Diarrhea, Abdominal pain |
Brain and nerves | 2 | Ataxia, Sudden, brief involuntary muscle jerks (myoclonus) |
Growth and development | 2 | Failure to thrive, Weight loss |
Blood and immune system | 1 | Low red blood cell count (anemia) |
Metabolism | 1 | Fever |
Bones and joints | 1 | Bone pain |
Heart and blood vessels | 1 | Hypertension |
Skin | 1 | Skin nodule |
Laboratory research |
19 |
31% |
Research summaries | 8 | 13% |
New treatment approaches | 3 | 5% |
Testing and diagnosis research | 2 | 3% |
Other research | 1 | 2% |
Kawathe R (2026). [PMID: 41392380](https://pubmed.ncbi.nlm.nih.gov/41392380/). *J Appl Toxicol*. [Basic Science / Preclinical]
Kyriakidis I (2026). [PMID: 41982370](https://pubmed.ncbi.nlm.nih.gov/41982370/). *Cureus*. [Epidemiology / Natural History]
Feng T (2026). [PMID: 41984207](https://pubmed.ncbi.nlm.nih.gov/41984207/). *Pediatr Surg Int*. [Epidemiology / Natural History]
Avanatti M (2026). [PMID: 41897445](https://pubmed.ncbi.nlm.nih.gov/41897445/). *Antioxidants (Basel)*. [Epidemiology / Natural History]
Xue E (2026). [PMID: 41221671](https://pubmed.ncbi.nlm.nih.gov/41221671/). *Head Neck*. [Basic Science / Preclinical]
Rovigatti U (2026). [PMID: 41352619](https://pubmed.ncbi.nlm.nih.gov/41352619/). *Crit Rev Oncol Hematol*. [Review / Meta-Analysis]
Sah DK (2026). [PMID: 42072162](https://pubmed.ncbi.nlm.nih.gov/42072162/). *Antioxidants (Basel)*. [Basic Science / Preclinical]
Chang J (2025). [PMID: 40340897](https://pubmed.ncbi.nlm.nih.gov/40340897/). *Hum Genomics*. [Epidemiology / Natural History]
Long C (2025). [PMID: 41273465](https://pubmed.ncbi.nlm.nih.gov/41273465/). *Mol Neurobiol*. [Epidemiology / Natural History]
Gillani R (2025). [PMID: 39745975](https://pubmed.ncbi.nlm.nih.gov/39745975/). *Science*. [Epidemiology / Natural History]